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Abstract-Tumor cells prepared from PRL-secreting rat pituitacy 73 156 tumors qf increa.ting 
weight were separated on continuous Percoll density gradients, according to d$jerences in their 
density. Whether the cell subpopulations obtained E$ dens& gradient separation .\hou,ed differences 
in protein content per cell, PRL production per cell, groutth rates and respon.kenej.c to the 
somatostatin analog SMS 20 l-995 in vitro relas investigated. In addition, we .studied PRL release 
ly individual 7315b tumor cells, using the reverse hemolrtirplayue a.rsq (RIfP:l). 
The tumor cells,from tumors “j-increasing akeight were recoupred within a narrow den@ range 
( 1 .CNX-1.070 g/ml) and shozed a normal distribution projile. There alere no di&rences betnleen the 
subpopulations with respect to the parameters mentioned above. .Moreover, no &fjPrenres were found 
with respect to these parameters between tumor cells derked from tumors qf inrrea.\ing useight. In 
agreement with the above data wefound no eGdencefor sublvpes of adenoma cells beingpreferential!p 
responsive to SMS 20 l-995, using the RHPA. Conclusions: ( 1) the tramplantable PRL-secreting 
rat pituitary tumor 73 I56 comists of a functiona& homogeneous cell populatron; (2) growth of 
this tumor in viva does not lead to the induction of j‘unctional!s heterogeneous cell .subpopulations 
within this tumor; (3) the escape of this tumor from the tumor growth-inhibitoyy effect of SdlS 
201-995. which has prerlious~,~ been demonstrated in viva, mg not harme been the result of rlonal 
selection of somatostatin-unresponsizle cells. 
INTRODUCTION 
MOST murine and human solid tumors show intra- 
tumor heterogeneity. Tumor cell populations can he 
heterogeneous for many phenotypic characteristics 
such as karyotypc, biochemical profile (e.g. levrls 
of various enzymes), hormone receptor content and 
drug or radiosensitivity [ 11. Little is known, how- 
ever, with respect to functional heterogeneity within 
pituitary tumors. Although it has been demon- 
strated that both human and rat pituitary tumors 
may consist of subpopulations of cells secreting 
more than one hormone simultaneously 12-71, a 
possible differential responsiveness of these tumor 
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cell subpopulations to hypothalamic regulatory hor- 
mones or to drugs has not been investigated exten- 
sively. In addition, it is not known whether, when 
cell proliferation occurs in z&o, all cells within a 
pituitary tumor cell suspension show similar growth 
rates. A knowledge of the intratumor heterogeneity 
ofpituitary tumors can be helpful in the understand- 
ing of the effects of certain drugs on the growth of 
the tumor cells or on the regulation of hormone 
release by these tumor cells in viuo and in vitro. The 
somatostatin analog SMS 201-995 has previously 
shown to inhibit the growth of the transplantable 
prolactin (PRL)-secreting rat pituitary tumor 
7315, in viva [8]. However, this tumor rapidly 
‘escaped’ from the tumor growth-inhibitory effect of 
SMS 201-995. In this study [8], one could not un- 
equivocally exclude the possibility that this ‘escape’ 
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might have been due to clonal selection of (0.4 g/l). The latter cell suspension was used for 
somatostatin-unresponsive tumor cells. Percoll gradient separation. 
The aim of the present study was to investigate 
whether functional heterogeneity exists within and 
between 7315b PRL-secreting rat pituitary tumors 
of increasing weight. For this purpose we used 
Percoll density gradient centrifugation of acutely 
dispersed 7315b tumor cells in order to obtain 
subpopulations of tumor cells with different densit- 
ies. The study investigated whether the subpopula- 
tions of tumor cells differed in (a) growth rates, 
(b) protein and PRL content of the cells and (c) re- 
sponsiveness of the tumor cells to the inhibitory 
effect of the somatostatin analog SMS 201-995. 
Since pituitary tumor cells do not store large 
amounts of hormone and because the density of the 
cells may be dependent on the mass of protein 
hormone present in the cytoplasm [9], the method 
ofdensity gradient separation may not be an appro- 
priate method for the study of functional heterogen- 
eity among cells of the 7315b tumor with respect to 
PRL release. Therefore, we also investigated PRL 
release by 7315b tumor cells at the single cell level, 
using the reverse hemolytic plaque assay (RHPA) 
POI. 
Separation of dispersed cells on continuous Percoll density 
gradients 
MATERIALS AND METHODS 
Animals, tumorgrowth in vivo andpreparation of dispersed 
tumor cells 
The origin of the transplantable PRL-secreting 
7315b rat pituitary tumor is described in detail 
elsewhere [l 11. This tumor originated from the 
ACTH-PRL-secreting 73 15a tumor but has lost its 
ability to secrete ACTH as well as its receptors for 
glucocorticoids. It is unchanged with respect to PRL 
secretion, and estrogen and progesterone receptor 
content [l 11. Female buffalo rats (Harlan, Madison, 
U.S.A.) weighing 160-180 g were inoculated sub- 
cutaneously between the scapulae with 0.2 ml of a 
suspension of the 7315b tumor. This suspension 
was prepared by mincing 20 g of tumor tissue in 
50 ml sterile saline (9 g NaCl/l). The rats were kept 
in an artificially illuminated room (09.00-21 .OO h) 
with food and water ad libitum. Two, 3 and 4 weeks 
after inoculation of the tumor cell suspension, rats 
were killed by an overdose of ether anesthesia and 
tumors of 7, 11 and 40 g were removed and collected 
in sterile saline. 
A 90% Percoll solution was made by mixing nine 
parts of Percoll stock solution (Pharmacia Fine 
Chemicals Uppsala, Sweden) with one part of a 
10 times concentrated calcium- and magnesium- 
free Hank’s balanced salt solution (Gibco, Europe). 
This 90% iso-osmotic Percoll solution was further 
diluted to 50% (density 1.070 g/ml) with phosphate 
buffered saline (pH 7.4). Eight milliliters of the 50% 
Percoll solution were then added to polypropylene 
tubes (Sorvall; 12 ml, 16 X 102 mm). To one tube, 
which was treated the same as all other tubes, 
calibration density marker beads (Nos 2-9, Phar- 
macia, Uppsala, Sweden) were added. Gradients 
were pre-formed by centrifugation at 25,300 gin a 
Sorvall SS-34 rotor during 30 min at 20°C. For cell 
separation, approximately 1.5 X lo7 to 2 X lo7 
cells in 2 ml HBSS + HSA were layered on the pre- 
formed gradients and then centrifuged at 800 g 
during 20 min at 20°C. The gradients were fraction- 
ated using an Auto Densi-Flow II C (Searle, Bachler 
Instruments, Fort Lee, New Jersey, U.S.A.; US 
Pat. No. 3682305). Twelve fractions (833 l.~l per 
fraction) were collected from the top ofthe gradients. 
Each fraction was then diluted (twice) with HBSS 
+ HSA and centrifuged for 5 min at 600 g. The 
cells were washed twice more with HBSS + HSA 
and finally resuspended in culture medium (see 
below). The counting of the cells in each fraction 
was done with a Biirker counter chamber. The 
viability of the cells was determined by trypan blue 
exclusion. 
After centrifugation, calibration of the formed 
density gradients was done by measuring the dis- 
tance of each density marker bead to the meniscus 
of the Percoll fluid. Cell recovery from the gradients 
yielded 86 +- 8% ( mean + S.E.; n = 3 independent 
experiments). 
Cell culture 
The 7315b pituitary tumor cells were isolated 
by mechanical dispersion as described in detail 
elsewhere [l 11. The viability of the resulting cell 
suspension was always greater than 90%. The cells 
were resuspended either in culture medium (for 
culture of the original, unfractionated cell suspen- 
sion) or in Hank’s balanced salt solution (HBSS) 
supplemented with 10 g/l human serum albumin 
(HSA), penicillin (10” U/l), streptomycin (100 mg/ 
l), fungizone (0.5 mg/l) and sodium bicarbonate 
The culture medium used in all experiments is 
minimal essential medium with Earle’s salts (MEM) 
supplemented with MEM non-essential amino 
acids, sodium pyruvate (1 mmol/l), 10% fetal calf 
serum (FCS), penicillin ( 10” U/l), streptomycin 
(100 mg/l), f un izone g (0.5 mg/l), L-glutamine 
(2 mmol/l) and sodium bicarbonate (2.2 g/l final 
concentration). The medium was adjusted to 
pH 7.4 with 1 mol/l NaOH. The 731513 pituitary 
tumor cells were seeded at a density of 25,000 viable 
cells per well in 1 ml of culture medium in 24-well 
plates (Costar, Cambridge, Massachusetts, U.S.A.) 
without or with SMS 201-995. After 6 days of 
culture the media and cells were collected and stored 
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at - 20°C until analysis. Medium and supplements 
were purchased from Grand Island Biological Co. 
Europe (Paisley, U.K.). SMS 201-995 was a gift 
from Sandoz (Basel, Switzerland). 
Reverse hemolyticplaque assay (RHPA) 
The reverse hemolytic plaque assay was perfor- 
med as described in detail elsewhere [lo]. In short, 
freshly dispersed (unseparated) and 6-day cultured 
cells (which had not attached to the floor of the 
wells) were harvested, centrifuged and resuspended 
in MEM + 0.1% bovine serum albumin (BSA; 
Sigma). A suspension of 150,000 cells/ml was mixed 
with an equal volume ofa 12% suspension ofprotein 
A-coated ovine red blood cells (oRBC). This cell 
mixture was infused into Cunningham chambers, 
which were prepared on poly-L-lysine-coated glass 
slides. After 1 h of incubation at 37°C in a CO, 
incubator the chambers were rinsed twice with 
MEM + BSA. Thereafter, incubations were started 
by infusing rabbit anti-rat PRL serum (1:50 final 
dilution in MEM + BSA) without or with 10 nmol/ 
1 SMS 201-995. The anti-rat PRL serum was a 
kind gift of Dr D.A. Leong (University of Virginia, 
Charlottesville, U.S.A.). The specificity ofthis anti- 
serum was described previously in detail [ 121. After 
24 h of incubation at 37°C in the CO, incubator 
the chambers were filled with immunoglobulin- 
stripped guinea pig complement [12] at a dilution 
of 1:20 in MEM + BSA. The choice ofan incubation 
time of 24 h was based on several experiments using 
increasing incubation times (not shown). 
After 45 min of incubation with complement, 
during which time plaque formation occurred, the 
reaction was stopped by infusing fixative (2% gluta- 
raldehydc in phosphate-buffered saline, pH 7.4). 
The 7315b cells were stained with hematoxylin in 
order to ensure the detection of non-plaque forming 
cells. All incubations were performed on duplicate 
slides and 100 cells per slide were counted. Plaque 
areas were measured with a calibrated ocular 
micrometer. A Leitz Dia\:ert microscope was used 
at 400-fold magnification. 
.4ssa_ys 
Rat PRL concentrations in the culture media 
were measured by a double antibody RIA using 
materials and protocols supplied by the distribution 
officer of the NIADDK. All results are expressed in 
rat PRL reference preparation (RP- 1). 
The DNA content of the tumor cells was deter- 
mined as described in detail elsewhere [ 131. The 
method is based on a DNA-dependent fluorescence 
enhancement of a Auorochrome. In short, freshly 
isolated tumor cells (25,000 cells) or the cultured 
tumor cells at the end of the incubation period 
(which did not attach to the floor of the wells) were 
collected and washed twice with an ice-cold saline 
solution, The remaining cell pellet was stored at 
-20°C until analysis. The cells were extracted with 
300 p,l ammonia solution (1 mol/l) - Triton X 100 
(0.2% v/v) by sonification during 5 s at amplitude 
15 (Soniprep 150; MSE). Thereafter 2 ml assay 
buffer (100 mmol/l NaCl, 10 mmol/l EDT%, 
10 mmol/l Tris; pH 7.0) was added. The remaining 
solution was centrifuged at 2000 g during 5 min 
and 100 ~1 aliquots of the supernatant was mixed 
with 1.5 ml Hoechst dye H33258 (100 kg/l). Fluo- 
rescence was measured after 15 min with the cxci- 
tation and emission wavelengths set at 350 and 
455 nhl respectively. The fluorescence of rxper- 
imental samples was referenced to a standard curve 
of calf thymus DNA (type II, no D-3636; Sigma 
Chemical Company, St Louis. MO, U.S.A.). 
The protein content of the tumor cells was csti- 
mated using the reagent kit from Bio-Rad (Rich- 
mond, CA) with BSA (Sigma) as standard. For 
estimation of the protein content of the crlls the 
same cell extracts were used as those used for DNA 
determination. 
=Inalysis of data 
The statistical significance of the differences 
between mean values was determined using onc- 
way analysis of variance (ANOVA). When signili- 
cant overall effects were obtained by ANOV,4, 
multiple comparisons were made using the 
Newman-Kculs test [ 141. All data are expressed as 
mean * S.E.M. We considered a dillercncc between 
mean values to be statistically significant when 
P < 0.01 because each experiment \zhich is prc- 
sented represents a single experiment. 
‘Growth rates’ of the cells were calculated as 
follows: the number of doublings in 144 h is b-a in 
which a = log,(DNA t = 0 h) and b = log,(DNA 
1 = 144 h). This method ofcalculation ofthc growth 
rate of cells has been previously described by 
Patterson [ 151. 
RESULTS 
Figure 1 shows the distribution of the rccovrred 
viable cells after separation of 7315b tumor cell 
suspensions derived from tumors of increasing 
weight on continuous Percoll density gradients. In 
the figure the density profiles of the gradients arc 
also indicated. The profiles of the recovered cells 
from the different tumors were completely similar 
in that they all showed a normal distribution with 
the majority of the cells being recovered in a narrow 
density range between densities of 1.060 and 
1.070 g/ml. Since in the fractions 4-6 and 9-l 1 not 
enough cells were recovered in order to perform 
culture studies, we used pooled fractions. With these 
pooled fractions the experiments as described below 
were performed. The pools arc indicated in Fig. 1 
by I. II and III on the x-ordinate. 
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Fig. 1. Projles of recovered Gable cells in the gradient fractions after 
separation of 73 156 tumor cells derirledfrom tumors of increasing weight 
(7, 11 and 40 g) on continuous Percoll densi& gradients (0-O). The 
dewily profile of the Percoll gradient is indicated 4v the interrupted line 
(O---O). Each point on this dens+ projile represents the position of 
density marker beads each having a specijc densi@ in the gradient. The 
symbols I, II and III which are indicated on the x-ordinate represent the 
pooledfractions that were used in the S-day culture studies (pool I, II and 
III cells). 
In none of the tumors were there statistically 
significant differences in the amount of protein per 
ng DNA between pool I, II and III cells. This 
is shown in Table 1. In addition we found no 
statistically significant difference of protein per 
DNA between the tumors of different weight 
(Table 1). 
Table 2 shows that the amount of DNA signifi- 
cantly increases from t = 0 to t = 144 h of culture 
(in all instances P < 0.01) indicating that the cells 
are growing during this period. In order to compare 
the ‘growth rates’ of the different tumors (7, 11 and 
40 g) and pool I, II and III cells, we calculated for 
each suspension the number of doublings which 
took place during the 144 h culture period. Calcu- 
lation of the number of doublings was done accord- 
ing to the method described in the Materials and 
Methods section. Fibroblast contamination and 
influence of the proliferation of these cells on the 
‘growth rate’ data of the 73 15b cells can be excluded 
because fibroblasts (if present) attached to the floor 
of the wells while the 7315b cells did not (see 
Materials and Methods). The cultured 7315b could 
be harvested by removing the culture medium plus 
cells thereby not collecting the fibroblasts present. 
We found no statistically significant differences 
between the tumors of 7, 11 and 40 g with regard 
to the latter parameter. In addition there were also 
no major differences between pool I, II and III cells 
with respect to the number of doublings in 144 h 
except for the fact that pool I cells showed in 
virtually all instances a significantly lower ‘growth 
rate’ than pool II and III cells (P < 0.01 for pool I 
vs. pool II and III cells). Only the 40 g tumor 
pool I and II cells had no different ‘growth rates’. 
Analysis of the viability ofpool I, II and III cells at 
time of plating and after 24 h of culture revealed 
that pool I cells always showed a slightly lower 
viability than pool II and III cells (data not shown). 
However, between 0 and 24 h there were no differ- 
ences in the viability of the cells. Routine light 
microscopic evaluation of cytospin preparations 
showed no differences between the original cell 
suspension and pool I, II and III cell suspensions. 
In all instances the majority of cells were tumor 
cells with only a few cells being white blood (host) 
cells (less than 2% ofthe cell population). 
Because PRL is the major protein hormone prod- 
uced by the 7315b tumor cells, we also determined 
the amount of intracellular PRL in the cells of the 
original cell suspension and of pool I, II and III 
cells, directly after isolation and after 6 days of 
culture. Since the number of cells significantly 
increases during culture and because the ‘growth 
rates’ of the pool I, II and III cells showed signifi- 
cant differences, we expressed the amount of intra- 
cellular PRL as the ratio over DNA. The results are 
shown in Table 3. Again no statistically significant 
differences were observed between the 7, 11 and 
40 g tumors and between pool I, II and III cells. 
The ratio of PRL over DNA after 6 days of culture 
was in all instances significantly higher (approxi- 
mately IO-fold; P < 0.01 in all instances) than the 
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Table 1. Protein content per ng of DNA of Percoll gradient fractions (directly after isolation) 










Original suspension 348 f 32 550 + 30 482 2 57 
Pool I cells 534 ? 37 683 + 58 542 2 ‘1’) ._ 
Pool II cells 426 ‘- li 568 -t 46 532 + 22 
Pool III cells 441 + 35 609 2 31 550 t 42 
Values in mean k SE.; n = 4. 
Cell suspensions derived from 7315b tumors of increasing weight were separated according 
to differences in their density on continuous Percott density gradients. Several gradient 
fractions were pooled in order to obtain pool I, II and III cells (see also legend to Fig. 1). 
Aliquots from each suspension containing 25,000 viable crlts were analyzed for prokin and 
DNA content. 
Table 2. Number of doublings in the original cell suspensions and in the Percoll gradient fractions after 6 days 
(144 h) of culture 
Tumor 
weight Cell suspension 
DNA (t = 0 h) DNA (t = 144 h) ‘Growth rate’ (number of 
(ng) (na) doubtings in I44 h) 
7g Original suspension 332 2 10 948 + 21* 1.51 f 0.03 
Pool I cells 267 2 6 456 k 13* 0.77 2 0.05 
Pool II cells 418 + 20 1597 + 53* 1.93 2 o.o5t,: 
Pool III cells 386 ? 23 858 5 25* 1.15 ‘- 0.04t 
‘1 g Original suspension 293 + 6 1007 e ,I 1.77 2 O.Ui 
Pool I cells 203 2 12 368 k 12* 0.85 +- 0.05 
Pool II cells 270 + 4 913 +- 27* 1.76 + 0.04t 
Pool III cells 240 5 10 902 k 50* I.89 2 0.0’3 
40 g Original suspension 440 2 9 1407 t 96’ 1.65 C 0.10 
Pool I cells 300 + 7 672 2 37* I.16 t 0.08 
Pool II cells 360 lr 19 873 -+ 51’ 1.26 ” 0.09 
Pool III cttts 309 + 17 875 k 29* 1.50 r 0.05t 
Cell suspensions derived from 7315b tumors of increasing weight were separated on continous Percott density 
gradients (see legend to Fig. 1). 25,000 cells of the original cell suspension and of the pooled fractions were 
initially seeded (in six-fold) and subsequently grown for 6 days (t = 144 h) in MEM + 10% FCS. The DNA 
content of the cells was determined directly after isolation and after 6 days of culture. ‘Growth rates’ were 
calculated as described in the materials and methods section. Yaturs in mean f S.E.; n = 1 IOr DN.4 (t = 0 h) 
and n = 6 for DKA (1 = 144 h). 
*P < 0.01 vs. DNA (1 = 0 h); tP < 0.01 vs. number of doublings in 144 h of pool I cells; :P < U.Ot vs. number 
of doublings in 144 h of pool III cells. 
Table 3. Rat prolactin (PRL) content per ng DNA of the original cell suspension and of Percoll gradient fractions of 73 156 tumors of 
increasing weight directly after isolation and after 6 days of culture (t = 144 h) 
ratio PRLDNA (pg:ng) 
7 g tumor 11 g tumor 40 g tumor 
Directly after After 144 h of Directly after After 144 h of Directly after Afrrr 144 h of 
isolation culture isolation culture isolation culture 
Original suspension 3.0 2 0.5 52.0 + 1.8* 3.5 2 0.2 48.1 ? 2.7* 3.7 ? 0.2 44.0 ? 1.6* 
Pool I cells 4.2 + 0.6 59.5 * 3.5* 4.5 + 0.2 41.4 t 1.8* 3.5 t 0.2 37.4 t 3.0* 
Pool II cells 3.7 2 0.1 44.7 2 1.9*,t 4.4 + 0.1 49.2 2 4.51 2.8 k (I.2 36.3 k 2.6* 
Pool III cells 3.3 t- 0.4 60.0 k 2.5* 4.9 k 0.6 56.5 2 3.5* 3.3 + 0.2 27 4 2 2.0’ 
Values in mean + S.E.; *P < 0.01 vs. PRLDNA directly after isolation; tP < (1.01 vs. pool I and III cells. 
Ser legend to Table 2. 
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PRL:DNA ratio directly after isolation indicating 
that the cells contain virtually no PRL directly after 
isolation and that they restore their capacity of PRL 
storage during the 6-day culture period. 
Finally, we also determined the responsiveness of 
the cells in the original cell suspension and in 
pool I, II and III to 10 nM SMS 201-995. This 
concentration of the drug had no effect on the 
growth ofthe cells (data not shown) but significantly 
inhibited the amount ofintracellular PRL and PRL 
release by the cells over the 6-day culture period (in 
all instances P < 0.01 vs. control PRL release; Fig. 
2). There were no statistically significant differences 
in SMS 201-995 responsiveness between the cell 
suspension of the 7, 11 and 40 g tumor and between 
pool I, II and III cells. 
In order to further investigate functional hetero- 
geneity among 731513 tumor cells with respect to 
PRL release, we also studied PRL release by individ- 
ual cells in unseparated 731513 cell suspensions 
using RHPA. Freshly dispersed 7315b cells did 
not secrete sufficient amounts of PRL to produce 
plaques in the 24 h incubation. This was probably 
due to the low amount of intracellular PRL directly 
after cell isolation (see Table 3). However, using 6- 
day cultures of 7315b cells 58 * 4% of the tumor 
cells formed plaques. Ten nmol/l SMS 201-995 did 
not significantly affect the percentage of plaque 
forming cells (56 ?z 8%). However, the drug signifi- 
cantly (P < 0.01 vs. control without SMS 201-995) 
inhibited the mean plaque area (mpa) by 47% (mpa 
of control cells being 4584 + 226 pm’ and mpa of 
cells incubated with 10 nmol/l SMS 201-995 being 
2421 * 23 pm2). The mpa represents the mean 
amount of PRL released by 100 cells. Figure 3 
shows the frequency distributions of the individual 
PRL plaque areas produced by unseparated 7315b 
tumor cells in the absence (closed symbols) or in 
the presence (open symbols) of 10 nmol/l SMS 
201-995. The frequency distribution shows, under 
control conditions, a unimodal mode with a slight 
skewness toward the larger plaques. In the presence 
of 10 nmol/l SMS 201-995, the frequency distri- 
bution shifts toward the smaller plaques. However, 
the shape of the frequency distribution was not 
affected by treatment of the cells with SMS 201- 
995 which may indicate that the drug did not 




ITis. 2. The effect of 10 nL\l SMS 201-995 on the release of PRL in 6 
dcys by the original cell suspension (0) and bv pool I, II and III cells 
(see legend to Fig. 1) of 73156 tumors of increasing weight (7, 11 and 
40 g). The cells u,ere initial!v seeded as 25,000 cells per well (in four- 
Jbld) nnd grou’n in .WEZI + 10% FCSfor 6 da)‘s. At the end of the 
culture period the media ulere collected and stored at -20°C until am&is 
of. PRL. The mluec ore expressed as the percentage of PRL release in 
log plaqueorea (prn2) 
Fig. 3. Frequency distributions of individual PRI. plaque areas 4)’ 
unseparated 73 156 ratpituitan’ tumor cells, in the absence (closedsymbols) 
or in the presence (open symbols) of 10 nmol/l S;1IS 201-995. Each point 
in the frequency distribution represents the mean result ,fiom two slides 
uutreated utells. *P < 0.01 L’S, control release. ( 100 plaques were measured per slide). 
DISCUSSION 
It is well established that most murine and human 
tumors show intrinsic cellular heterogeneity [I]. 
Until now, however, little is known whether human 
pituitary tumors or transplantable rat pituitary 
tumors such as the GH,, MtT/W15 and 7315a or 
b tumors also show functional heterogeneity with 
regard to cell growth characteristics and/or respon- 
siveness to regulatory hormones or steroids. Three 
of these experimental tumors have been shown to 
produce more than one hormone simultaneously. 
GHs and MtT/W15 tumors contain both single 
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(GH or PRL) and dual hormone secretors (GH and 
PRL) as determined by the reverse hemolytic plaque 
assay [5-71, while 73 15a tumors produce both PRL 
and ACTH [8]. Boockfor el al. [6] have demon- 
strated that cultures of GH, cells are also function- 
ally heterogeneous. They showed that chronic treat- 
mcnt of cultures of GH,< cells with TRH, estradiol 
or cortisol caused reciprocal shifts in the proportions 
of GH and PRL cells present. Although their data 
were suggestive of interconversion of GH cells into 
PRL cells and ZJ~C~ uersa they could not preclude 
the possibility that other processes (such as cell 
proliferation) were involved. The present study was 
undertaken in order to evaluate whether functional 
heterogeneity ofcells within the transplantable ‘pure’ 
PRL-secreting pituitary tumor 73 15b exists, with 
respect to growth rate, PRL production and respon- 
siveness to the somatostatin analog SMS 201-995. 
WC separated freshly dispersed 7315b tumor cells 
derived from tumors of increasing weight on con- 
tinuous Percoll density gradients, according to dif- 
fercnces in their density. The technique of density 
gradient centrifugation has previously been shown 
to provide a useful tool for the study of intratumor 
cell heterogeneity [ 16, 171. The distribution of 
the 731513 cells derived from tumors of increasing 
wright on the Pcrcoll gradients showed a normal 
distribution profile with the cells being recovered 
between a narrow density range. This homogeneous 
distribution indicates that the cells within the 73 15b 
tumor arc physiologically homogeneous. In this 
respect the observations by Grdina et al. [ 181 show- 
ing that the distribution of tumor cells obtained 
from density gradient centrifugation reflects the 
hetcrogcneity within tumors is ofinterest. In agree- 
ment with the homogeneous profile with respect to 
the density of the cells we found no differences 
brtwcen the Pcrcoll gradient fractions with respect 
to protein content per cell, PRL production per cell 
and responsivcnrss to the inhibitory effect of the 
somatostatin analog SMS 201-995. In addition, we 
found no diffrrcnces between tumors of increasing 
weight (7, 11 and 40 g) with respect to these par- 
ameters and with respect to the growth rates of the 
tumor cells in vitro. Therefore, it can be concluded 
that the 73 15b transplantable PRL-secreting pitu- 
itary tumor is homogeneous with regard to its 
crllular composition and that growth of 7315b 
tumors in rlivo dots not lead to the induction of 
heterogeneous subpopulations as has been 
dcscribcd for most human and murine solid tumors 
[ 1 1. The lack of heterogeneity between the gradient 
fractions in responsiveness to the somatostatin 
analog SMS 201-995 may exclude clonal selection 
of somatostatin-unresponsive cells leading to ‘esca- 
pe’ of the tumor from the tumor growth-inhibitor) 
efrcct of this drug as has been described prcviousl) 
[8l. 
Since the 731510 pituitary tumor ~11s do not 
store large amounts of PRL, the method ofdensit) 
gradient separation may not have been an appropri- 
ate method for the study of functional hctcrogenrit) 
among 7315b tumor cells with respect to PRI. 
release. Therefore, we also used an altornatc tech- 
nique, RHPA, which has been prcviousl) show~l 
to detect functional subtypes of hormone-sccrcting 
cells in unseparated, normal rat anterior pituitar!- 
cell suspensions [19-221. The results of our cspcr- 
iments using the RHPA for the dctrction of PKI, 
release by individual 7315b cells basicall!, con- 
firmed our cell separation data. In agrcscmcnt with 
the latter data we found no cvidcncr for a ditfrrrntial 
responsiveness to SMS 201-995 among cells of the 
7315b tumor. Only- with resprct to basal PRI, 
release have we demonstrated that thcrc’ was ‘1 
minor population of adcnoma crlls sccrcting a high 
amount of PRL. 
The only difference that was ohscrvctti in our 
study between thr Percoll gradirnt fractions was ;I 
slightly lower growth ratr ofthe crlls in the gradient 
fraction with the lowest density-. It is unlikrl>. that 
this particular fraction rrpresrnts a subpopulation 
of tumor cells in a non-proliferating or cluicsccnt 
state [23, 241 caused b) nutrient dcpri\.ation (11‘ 
the tumor cells in ho. First, stud& using drnsit!, 
gradient centrifugation ofmurinr fibrosarcoma rrlls 
have previously shown that thrsc particular subpo- 
pulations are reco\rrrcd in the high drnsit) rrgion 
of density gradients [16. 171, \vhilc sc~~~ndl~ \v( 
observed no shifts in the dcnsit)- distribution profile 
of tumor cells drrived from tumors 01‘ inc-rcasing 
weight and no diffcrcncrs brt\t.ccn thcsc. tumors 
with respect to their growth rates in Stro. ‘l‘hcrrforc. 
the most likely explanation for thr Iolvcr grobvth 
rate of the low density fraction is a lo\vcr \iabilit) ot 
the cells (or part of the ~11s) in this qradicnt 
fraction related to a limitrd life-span ol‘tht. c,rlls. In 
agreement with this is our ohsrr\ation that this 
fraction had a slightly lowcar \iabilit>. than the higher 
density fractions. 
In conclusion our study drmonstracrs that the 
transplantable PRL-secreting rat pituitar) tumor 
731513 consists of a homogrneous ccl1 population as 
measured by density distribution profile, protrin 
content of cells, growth rates and rcsponsivcnrss to 
the somatostatin analog SMS 201-993. Onl) with 
respect to PRL production per ccl1 may thcrr bc a 
small fraction of cells within the tumor ccl1 popu- 
lation secreting a high amount of PKI,. \\‘hrthc~ 
this tumor homogeneity is rrprcscntativr fi)r human 
pituitary tumors in genrral remains to lx c’stab 
lished. 
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